Read the full FDA Warning Letter here: #FDA #WarningLetter #PharmaCompliance #GLP1 #Semaglutide #Tirzepatide #DrugSafety #QualityMatters #Zenovel# To view or add a comment, sign in New FDA move to crack down on counterfeit drug ingredients: On September 4, 2025, the FDA launched the Green List a proactive step to block illegal imports of unapproved GLP-1 drug ingredients, like those used in weight loss and diabetes treatments such as semaglutide
Studies published in January and July 2024 showed an increased risk of NAION for patients using these drugs, with individuals who took them for weight loss at an even higher risk
Provide proof of your income (e.g, tax returns or payslips)
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
From mainstream news outlets to popular documentaries, the buzz about gut health is growing
What is the Deadline for Filing an Ozempic Lawsuit
